| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 14/05/2024 | 13:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ABSI | AbSci Corporation |
| 14/05/2024 | 13:32 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ABSI | AbSci Corporation |
| 14/05/2024 | 13:30 | GlobeNewswire Inc. | Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results | NASDAQ:ABSI | AbSci Corporation |
| 16/04/2024 | 14:00 | GlobeNewswire Inc. | Absci to Report Business Updates and First Quarter 2024 Financial and Operating Results on May 14, 2024 | NASDAQ:ABSI | AbSci Corporation |
| 28/03/2024 | 21:05 | GlobeNewswire Inc. | Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference | NASDAQ:ABSI | AbSci Corporation |
| 21/03/2024 | 12:30 | GlobeNewswire Inc. | Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results | NASDAQ:ABSI | AbSci Corporation |
| 01/03/2024 | 22:01 | GlobeNewswire Inc. | Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares | NASDAQ:ABSI | AbSci Corporation |
| 28/02/2024 | 14:34 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NASDAQ:ABSI | AbSci Corporation |
| 28/02/2024 | 04:20 | GlobeNewswire Inc. | Absci Announces Pricing of Public Offering of Common Stock | NASDAQ:ABSI | AbSci Corporation |
| 27/02/2024 | 22:01 | GlobeNewswire Inc. | Absci Announces Proposed Public Offering of Common Stock | NASDAQ:ABSI | AbSci Corporation |
| 21/02/2024 | 13:30 | GlobeNewswire Inc. | Absci Initiates IND-Enabling Studies for ABS-101, a Potential Best-in-Class Anti-TL1A Antibody de novo Designed and Optimized Using Generative AI | NASDAQ:ABSI | AbSci Corporation |
| 20/02/2024 | 14:00 | GlobeNewswire Inc. | Absci to Participate in Upcoming Investor Conferences | NASDAQ:ABSI | AbSci Corporation |
| 14/02/2024 | 00:16 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:ABSI | AbSci Corporation |
| 06/02/2024 | 01:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ABSI | AbSci Corporation |
| 10/01/2024 | 13:30 | GlobeNewswire Inc. | Absci Appoints Professor Sir Mene Pangalos to its Board of Directors | NASDAQ:ABSI | AbSci Corporation |
| 08/01/2024 | 13:00 | GlobeNewswire Inc. | Absci to Present Preclinical Data for ABS-101, A Potential Best-in-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:ABSI | AbSci Corporation |
| 04/01/2024 | 22:57 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:ABSI | AbSci Corporation |
| 03/01/2024 | 14:00 | GlobeNewswire Inc. | Absci to Participate in the 26th Annual Needham Growth Conference | NASDAQ:ABSI | AbSci Corporation |
| 28/12/2023 | 14:00 | GlobeNewswire Inc. | Absci to Participate in the 42nd Annual J.P. Morgan Healthcare Conference | NASDAQ:ABSI | AbSci Corporation |
| 20/12/2023 | 13:30 | GlobeNewswire Inc. | Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline | NASDAQ:ABSI | AbSci Corporation |
| 04/12/2023 | 16:41 | Dow Jones News | Absci Shares Rise 27% After Announcing Collaboration With AstraZeneca | NASDAQ:ABSI | AbSci Corporation |
| 04/12/2023 | 13:30 | GlobeNewswire Inc. | Absci Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate | NASDAQ:ABSI | AbSci Corporation |
| 15/11/2023 | 14:00 | GlobeNewswire Inc. | Absci to Participate in the Piper Sandler 35th Annual Healthcare Conference | NASDAQ:ABSI | AbSci Corporation |
| 14/11/2023 | 22:05 | GlobeNewswire Inc. | Absci Reports Business Updates and Third Quarter 2023 Financial and Operating Results | NASDAQ:ABSI | AbSci Corporation |
| 14/11/2023 | 08:16 | Business Wire | Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseases | NASDAQ:ABSI | AbSci Corporation |
| 21/09/2023 | 14:00 | GlobeNewswire Inc. | Absci Announces Speaker Lineup for Inaugural R&D Day, Including Renowned Global Business Leader Sandi Peterson and VP of Applied Research at NVIDIA Jonathan Cohen | NASDAQ:ABSI | AbSci Corporation |
| 06/09/2023 | 14:00 | GlobeNewswire Inc. | Absci to Host R&D Day on October 4, 2023 | NASDAQ:ABSI | AbSci Corporation |
| 14/08/2023 | 14:02 | GlobeNewswire Inc. | Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results | NASDAQ:ABSI | AbSci Corporation |
| 14/08/2023 | 14:00 | GlobeNewswire Inc. | Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer | NASDAQ:ABSI | AbSci Corporation |
| 10/08/2023 | 14:00 | GlobeNewswire Inc. | Absci and Caltech Join Forces, Bolstered by Major Grant, to Accelerate Affordable HIV Therapeutic Vaccine Development | NASDAQ:ABSI | AbSci Corporation |